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Abstract In this study, we try to detect and isolate the cancer
stem cell-like side population cells (SP) from the laryngeal
carcinoma cell line and primary laryngeal carcinoma and ex-
plore the clinical implications of SP cells in laryngeal carcino-
ma. The SP cells and non-side population cells (NSP) cells
were sorted by Hoechst 33342 through FACS. The prolifera-
tion capacity, invasion ability, migration ability, and tumori-
genic activity of the SP cells were evaluated. In addition, the
association between the SP cells ratio and the prognostic factors
of laryngeal cancer was analyzed. As a result, the percentage of
the SP cells in Hep-2 cells was 5.1 %. The SP cells depicted
float colonies, but the NSP cells failed to generate the typical
cell spheres. The clone formation ratios were 47.47±10.20 %
vs. 4.98±1.41 % in the flat plates and 46.82±5.67 % vs.
12.53±3.51 % in the soft agar for SP and NSP cells (P=0.01
and 0.01). The SP cells depicted a higher migrating potency
than the NSP cells in both the transwell assay and scarification
test (all P<0.05). The matrigel invasion assay showed that the
artificial basement membrane penetration rate of SP cells was
39.04±4.78 %, which was higher than 25.16±4.63 % of the
NSP cells (P<0.05). Only 103 SP cells were able to form
tumors in mice, whereas 104 NSP cells failed to form tumors.
The SP cells were correlated with the differentiation, lymph
node metastasis, and clinical stage of the laryngeal cancers. In
conclusion, SP cells may be a potential prognostic factor of
laryngeal cancer.
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Introduction
Laryngeal cancer is one common disease in head and neck
cancers, and its incidence has increased year by year [1]. In
recent years, comprehensive treatment measures such as
functional laryngeal surgery, radiotherapy, chemotherapy,
concurrent chemoradiotherapy, and gene therapy have
gained a higher 5-year survival rate for patients with laryn-
geal cancers, but 30 % to 40 % of them still died of tumor
recurrence or metastasis [2, 3]. Hence, there is an urgent need
to explore the mechanism of origin, invasion, as well as
metastasis of the laryngeal cancer in order to design new
treatment methods [4].
Stem cells, which represent only a very small percentage of
the total tumor mass, have been found to be the source of some,
and possibly most, cancers [5]. The cancer stem cell hypothesis
states that certain stem cells remain in tissues to replenish them
after injury or disease, yet because they are self-renewing and
can survive for a longer period of time, the adult stem cells can
also accumulate mutations, which would cause them to pro-
duce cells that divide uncontrollably, forming a tumor [6–8].
Laryngeal cancer stem cell research is only in the initial stage,
but the cancer stem cell concept provides a new perspective
method for overcoming tumors, which could have an immea-
surable impact on the future of cancer research.
Due in part to the better understanding of cancer stem cell
theory, stem cell related genes in malignant tumors have gained
more academic attention. Currently, studies addressing laryn-
geal SP cells, especially based on the primary solid tumors, are
still rare. In the study herein, we try to sort and identify the
laryngeal SP cells in order to lay a foundation for the manage-
ment of laryngeal cancer.
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The laryngeal cancer cell line Hep-2 was provided by China
Center for Type Culture Collection (Wuhan, Hubei prov-
ince). BALB/c mice were 4–6 weeks of, weighed 15 to
18 g, and were provided by the Experimental Animal Center
of Lake Hayes. We selected 120 cases that were treated at the
Jilin University between Jan 2003 and Dec 2008 for the
prognostic analysis. The inclusion criteria were as follows:
(a) curative operations were performed; (b) resected speci-
mens were pathologically examined; (c) more than ten
lymph nodes were pathologically examined after operation;
and (d) a complete medical record was available. The study
protocol was approved by the Ethics Committee of Jilin
University.
Western blot analysis
Cells were prepared from 100 mg of SP and NSP cells.
Approximately 1×107 cells were harvested by trypsinization.
Cells were lysed in 200 μl ice-cold lysis buffer for 30min, and
the lysates were centrifuged at 12,000×g for 15 min. Protein
concentration was quantified using a protein measure Kit
(Xian RunDe Biotechnology Ltd.), then protein samples were
separated by sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis (12 % SDS-PAGE) and transferred onto nitrocel-
lulose membranes. For immunodetection, the membranes
were blocked in tris-buffered saline (TBS) containing 5 %
nonfat milk powder for 2 h at 4 °C, incubated with primary
antibodies to mouse anti-human ABCG2 monoclonal anti-
body (Santa Cruz Biotechnology, Inc., CA, USA), mouse
anti-human beta-actin monoclonal antibody (Santa Cruz Bio-
technology, Inc., CA, USA) overnight at 4 °C, and then
incubated in tris-buffered saline Tween (TBST) containing
horseradish peroxidase-labeled antibody against IgG for
90 min. Immunoreactive proteins were visualized using the
enhanced chemiluminescent detection system (BestBio,
Shanghai, China) according to the manufacturer's instruction.
Extraction of total RNA and reverse transcription followed
by PCR (RT-PCR)
Total RNA was extracted from approximately 1×10 [6] cells
using Trizol reagent (Invitrogen, USA) following the manufac-
turer's instructions. cDNAwas then synthesized from 2 μg total
RNA using oligo dT as the primer along with the MMLV
reverse transcriptase (Takara Inc, Japan). PCR was performed
with the following primers: ABCG2: sense 5′-AACGAACGG
ATTAACAGGG-3′, antisense, 5′-AAGGTGAGGCTATCAA
ACA-3′; GAPDH: sense, 5′-TGTCATCAATGGAAATCCC-
3′, and antisense, 5′-GAGACCACCTGGTGCTCA-3′. After
the PCR reaction, the products were loaded on 1 % agarose
gel and visualized by ethidium bromide staining.
Flow cytometry
The Hep-2 cells in logarithmic growth phase were added
Hoechst33342 to a final concentration of at 5 μg/ml and cul-
tured at 37 °C for 90 min. Violet, blue, and red-fluorescent
Hoechst33342 dye was excited when bound to 407, 450/40,
and 675/40 nm. PI excitation was at 488 nm blue and 633 nm
red light. Two-dimensional plot was drawn by Hoechst Red as
x-axis and Hoechst Blue as y-axis, and the verapamil missing
region is set to SP cells gate (gated), sorted SP cells, and NSP
cells. Each experiment was repeated three times.
Cell proliferation assay
Cells were seeded in 96-well plates and incubated at 37 °C in




(×400). a The cell nucleus
showed blue fluorescence
stained by Hoechst33342; b the
cell membrane showed red
fluorescence stained by CM-
DiI; c an overlay of panels a and
b is shown (arrow)
Table 1 ABCG2 protein expression in SP and NSP groups SP (x±S,
n=3)
Groups ABCG2/GAPDH absorbance ratio P
SP 0.391±0.058 0.003
NSP 0.04±0.006
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determined using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte
trazolium bromide (MTT) assay [9]. The absorbance was read
at 540 nm. Each experiment was repeated three times.
CCK-8 proliferation assay
The new sorting SP and NSP cells were centrifuged and
washed with PBS one time/per well in 100 μl (5×103/well)
and were seeded in 96-well plates. The 96-well plates were
cultured at 5 % CO2, 37 °C, and the medium was changed
every other day. One orifice was randomly selected at 1, 3, 5,
and 7 days after inoculation, and every well was added 10 μl
CCK-8 reagent. Then, the cells were measured for absorp-
tion values at a wavelength of 450 nm after 3 h incubation on
a microplate reader. The growth curves were drawn by the
growth days as abscissa and the absorbance as vertical axis.
Soft agar colony formation assay
The anchorage-independent growth of SP and NSP cells was
monitored by the soft agar colony formation assay. In brief,
cells (100/well) re-suspended in 1.5-ml mixture of 1.2 %
low-melt agarose and 2× RPMI 1640 (v:v=1:1) were loaded
in triplicate on the top of the solidified bottom agar compris-
ing equal-volume mixture of 0.7 % low-melt agarose and
RPMI 1640 in 12-well plates. The cells were incubated at
37 °C, 5 % CO2 for 2 weeks. The colonies composed of more
than 50 cells were counted.
In vitro migration and invasion assay
Cells growing in the log phase were treated with trypsin and re-
suspended as single-cell solution. Then, the cells were counted,
and 1×105 cells in 1 mL of serum-free RPMI 1640 medium
were split into the upper chamber of Transwell Boyden cham-
ber (8-μm pore size, BD Biosciences, USA), where the
transwell membrane was coated either with (for invasion) or
without (for migration) matrigel. Serum-free medium was also
added to the lower chamber. The migration assay proceeded in
37 °C, 5%CO2 tissue culture incubator for 12 h, and the
invasion assay for 18 h. The non-migrated/invaded cells in
the upper chamber were removed using a cotton swab, and
the migrated/invaded cells fixed in methanol and stained with
eosin for migrated cells or Giemsa for invaded cells. The cells
that were trapped in or attached to the reverse side of the porous
membrane were photographed through ×200 microscope ob-
jective, the numbers of migrated cells in at least five random
fields were counted under phase contrast microscope, and the
average was calculated [9].
Limiting dilution injection experiment
The sorted SP and NSP cells were re-suspended in serum-free
DMEM into a cell suspension containing 105, 104, 1×103
cells per 200 ul. Cells to be injected were then suspended in
RPMI1640/Matrigel mix (1:1 volume) and injected into the
appropriate area of the mammary fat pad.
Statistical analysis
All data were analyzed with SPSS statistics software (Version
13.0, Chicago, IL, USA).ΔΔCtMethod was employed in the
gene chip data analysis. The ΔCt was calculated for each
pathway-focused gene in each treatment group. ΔCt (group
1)=average Ct−average of HK genes' Ct for group 1 array.
ΔCt (group 2)=average Ct−average of HK genes' Ct for
Fig. 2 ABCG2 mRNA expression status of SP and NSP cells. ABCG2 mRNAwas higher in NP cells compared to NSP cells (a, P<0.05). ABCG2
protein expression status of SP and NSP cells. ABCG2 protein expression was higher in NP cells compared to NSP cells (b, P<0.05)
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group 2 array. ΔΔCt=ΔCt (group 2)−ΔCt (group 1). Rela-
tionships between SP ratio and clinic-pathological parameters
were studied using the chi-square test, Fisher's extract test, or
independent t tests. One-way ANOVAwas applied to test the
differences between groups for all in vitro analyses. ANOVA
test was used for the in vivo xenograft experiment. A P value
of less than 0.05 was considered statistically significant.
Results
The sorting of SP tumor cells of laryngeal cancer
The percentage of the Hoechst33342− cells (SP cells) was
5.1±0.25 % in Hep-2 cell line in immunofluorescence staining
(Fig. 1). The proportion of the sorted SP cells was 4.4±0.85 %
in FACS test, which decreased to 0.63±0.31 % after the
verapamil was added. The two group cells showed similar
characteristics with Hep-2 cells after cultured in DMEM with
10 % FBS. The expression of ABCG2 in SP cells was signif-
icantly higher than NSP cells (P<0.05) (Table 1; Fig. 2).
The identification of the stemness of SP tumor cells
After 7 days of culture, single-cell suspensions of SP tumor
cell produced viable mammospheres (20 to 100 μm), which
could be passaged further in serum-free suspension culture
Fig. 3 After 7 days of culture, SP tumor cells could produce viable
mammospheres in serum-free suspension culture condition (a), while
NSP cells could not (b). SP tumor cells got a higher node mice
tumorigenicity ability compared to NSP cells (c, g 105SP; d, h
104SP;e, i 103SP; f, j105 NSP). SP and NSP cell transplantation tumor
HE staining was shown (k SP cells, l NSP cells; ×400)
Table 2 Limiting dilution xenograft formation experiment
Groups 105 104 103
SP 5/5 4/5 2/5
NSP 4/5 0/5 0/5
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condition, while no mammosphere was produced by NSP
cells in the same culture condition (Fig. 3). As few as 103 SP
cells were able to form tumors in mice, whereas 104 NSP
cells failed to form tumors, which indicated that the tumor-
igenic activity of the SP cells were stronger than the NSP
cells (P<0.05) (Table 2) (Fig. 3).
The SP cells depicted float colonies, but the NSP cells
failed to generate the typical cell spheres. Furthermore, the
SP cells were integrated with big nucleolus and little cyto-
plasm under the transmission electron microscope, while the
NSP cells showed the small pyknosis of the nucleolus, with
significantly expanded endoplasmic reticulum and hetero-
chromatin (Fig. 4). In the CCK-8 proliferation assay, the
absorbance of the SP cells was higher than that of the NSP
cells in the third cultured day. The clone formation ratios
were 47.47±10.20 % vs. 4.98±1.41 % in the flat plates and
46.82±5.67 % vs. 12.53±3.51 % in the soft agar for SP and
NSP cells (P=0.01 and 0.01).
In the differentiation potency assay by FACS, the propor-
tion of the sorted SP cells was 4.2±0.47 % on the 14th day,
which was similar to that of the first time sorting
(4.4±0.85 %). Both the SP and NSP cells displayed a similar
cell cycle distribution in the cell cycle assay. The SP cells
depicted a higher migrating potency than the NSP cells in
both the transwell assay and scarification test (all P<0.05)
(Fig. 5). The matrigel invasion assay showed that the artificial
basement membrane penetration rate of SP cells was
39.04±4.78 %, which was higher than 25.16±4.63 % of
the NSP cells (P<0.05).
The relationship between SP cells and clinic-pathological
factors of the primary laryngeal cancers
SP cells existed in most of the primary laryngeal cancer cells,
and the average proportion of the SP cells from the 120 cases
of laryngeal carcinoma specimens is 3.1±2.36 %. SP cells
were correlated with gender, differentiation, lymph node
metastasis, and clinical staging of the laryngeal cancer
(P=0.021, 0.001, 0.001, and 0.001, respectively, Table 3).
Survival analysis revealed that SP cells ratio was associated
with laryngeal cancer-specific survival in 120 cases (87.77 %
vs. 63.49 %, P=0.001, log–rank test) (Fig. 6). After
performing a Cox regression, differentiation, lymph node
metastasis, clinical staging, and SP cells ratio were shown
to be the independent prognostic factors of laryngeal cancer.
Discussion
Recurrence and metastasis are two of the primary causes for
the death in patients with malignant tumors, which is the
biggest challenge for the tumor treatment [10]. Until now, the
fundamental causes for the genesis, recurrence, and metastasis
of the tumor have not been identified, although some progress
Fig. 4 The SP cells depicted float colonies as proliferating (a), but the
NSP cells did not generate the typical cell spheres (b). There was
significant difference in colonies' formation rates between the two groups
(c). SP cells were integrated with big nucleolus and little cytoplasm (d
×2,000, f ×5,000), while the NSP cells showed the small pyknosis of the
nucleolus under transmission electron microscope (e ×2,000, g ×5,000)
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has been made in the study of biology. The concept of the
tumor stem cell has supplied a new thread for the study of the
biological properties of the tumor, which make it possible for
targeting the tumor stem cell to kill them and thus prevent the
recurrence and metastasis of the tumor [11, 12]. This concept
has become the hot topic, but because most of the specific
makers of the cells are unknown, the isolation and identifica-
tion of the tumor stem cell is quite difficult [13, 14]. The side
population (SP) is a special type of the cell subpopulation, and
the isolation of SP cells is easy and mature [15].
Many researchers have checked out SP cells from various
normal and tumorous tissues [16, 17]. It was confirmed that
Fig. 5 The SP cells depicted a
higher migrating potency than
the NSP cells in both the
transwell assay (a SP cells; b
NSP cells) and scarification test
(c and d)
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compared with the NSP cells, SP cells from most tumor
tissues possessed faster proliferation and self-renewal proper-
ties; they formed tumors easier in immunodeficient mice and
had stronger drug resistance, for which the stem cell charac-
teristic cells were considered to be enriched in the SP cells.
At present, the study of cancer stem cells in laryngeal
carcinoma is still in the primary stage. Wang et al. [7] observed
that SP rates were 2.6 %, 0.1 %, 6.8 %, 1.8 %, and 0.7 % in
nasopharyngeal carcinoma cell lines CNE-2, C-666-l, SUNE-1,
HONE-1, and CNE-1, and the CNE-2 SP cells have a stronger
proliferation, differentiation capacity, and tumorigenicity com-
pared to the control group. In another study, Zhang et al. [8]
selected SP cells from oral cancer cell lines and 11 solid tumor
specimens and found that SP cells play an important role in the
incidence of oral cancer.
Our study investigated the biological properties of the SP
cells from the laryngeal cancer cell line Hep-2 and the
primary cultured laryngeal carcinoma cells, desiring to sup-
port a new approach and some experimental reference for the
study of laryngeal TSCs. In the study, the percentage of SP
cells was about 5.1 %, and the cells got high ABCG2 protein
expression compared to NSP cells. The sorted SP cells had
self-renewal properties and got strong proliferation and in-
vasion abilities. The SP cells formed tumors easier in immu-
nodeficient mice compared to the control groups.
Furthermore, the SP cells existed in most of the primary
laryngeal carcinoma cells and correlated with the differentia-
tion, lymph nodemetastasis, and clinical stage of the laryngeal
carcinoma.
Conclusion
The SP cells sorted from the laryngeal cancer cell line Hep-2
are tumor stem cell-like subpopulation that displays charac-
teristics of high proliferative, clone formation, differentiation
capacities, strong tumorigenic ability, and resistance of che-
motherapy drugs. The SP cells exist in most primary laryn-
geal carcinoma specimen cultured cells, which were corre-
lated with clinical pathological characteristics of the laryn-
geal carcinoma.
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